Biochemistry

G.I. Evan, A.H. Wyllie, C.S. Gilbert, et al., "Induction of apoptosis in fibroblasts by c-myc protein," Cell, 63:119-25, 1992. Gerard Evan (Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund, London): "Although cancer is a common disease, the cancer cell is extremely rare. We know this because it takes only one fully malignant cell (and its progeny) to form a lethal tumor, yet cancer afflicts only one in three individuals during the entire course of their lives. This is

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

G.I. Evan, A.H. Wyllie, C.S. Gilbert, et al., "Induction of apoptosis in fibroblasts by c-myc protein," Cell, 63:119-25, 1992.

Gerard Evan (Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund, London): "Although cancer is a common disease, the cancer cell is extremely rare. We know this because it takes only one fully malignant cell (and its progeny) to form a lethal tumor, yet cancer afflicts only one in three individuals during the entire course of their lives. This is even more surprising when one considers that an organism like man comprises billions of cells, many of which continuously proliferate throughout adult life. In principle, any cell that spontaneously acquires a growth advantage should automatically outgrow its siblings, spread, invade, and become a tumor. The fact that this happens so rarely is, therefore, one of the great mysteries of human biology.

"Proto-oncogenes are normal cellular genes that encode components of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies